This inventor holds 1 USPTO granted patent. Top assignee: Fudan University. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Jiani Mao: Innovator in Tumor Targeting Technologies
Introduction
Jiani Mao is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medical technology, particularly in the development of targeted therapies for tumors. His innovative work has the potential to enhance the effectiveness of cancer treatments.
Latest Patents
Jiani Mao holds a patent for a VAP polypeptide and its use in the preparation of drugs for targeted diagnosis and treatment of tumors. This invention includes highly stable D-configuration polypeptides, DVAP and SVAP, which exhibit a high binding activity to the GRP78 protein. Additionally, the patent describes an L-configuration polypeptide, LVAP, and a modified model drug, along with a macromolecule carrier material. These innovations are aimed at constructing tumor images and developing drug-delivery systems for targeted treatment.
Career Highlights
Jiani Mao is affiliated with Fudan University, where he continues to advance his research in the field of biotechnology. His work is characterized by a commitment to improving cancer diagnosis and treatment methodologies.
Collaborations
Some of his notable coworkers include Weiyue Lu and Cao Xie, who contribute to the collaborative efforts in his research projects.
Conclusion
Jiani Mao's innovative contributions to tumor targeting technologies exemplify the potential of biotechnology in enhancing cancer treatment. His work not only advances scientific knowledge but also holds promise for improving patient outcomes in oncology.